Endocrinology

Your Article Summary

See Latest Articles

Use of antiandrogens as therapy for women with polycystic ovary syndrome
Fertility and Sterility, 08/14/06

Paolo Moghetti M.D., et al - Because androgen excess plays a fundamental role in symptoms and, it is likely, in pathogenesis of polycystic ovary syndrome, attenuation of hyperandrogenism appears to be of paramount importance in the therapy of this condition. Consistently, drugs inhibiting androgen receptor binding not only are an effective tool in hirsutism treatment but also show favorable effects on body composition and metabolic features of these women

Today in Pharmacology/kinetics...keeping you current

Receive free subspecialty "5-minute updates" via email

Denosumab update
Current Opinion in Rheumatology, 06/11/09

Lipid-altering efficacy and safety of ezetimibe/simvastatin versus atorvastatin in patients with hypercholesterolemia and the metabolic syndrome (from the VYMET study)
The American Journal of Cardiology, 06/22/09

Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): A multicentre, randomised, open-label trial
The Lancet - Early Online Publication, 06/09/09

See All of Pharmacology/kinetics

Today in Reproductive Endocrinology...keeping you current

Receive free subspecialty "5-minute updates" via email

Andrology: Potential for diagnostic errors in men taking statins
NCP Urology, 06/11/09

Adequacy of a Single Unstimulated Luteinizing Hormone Level to Diagnose Central Precocious Puberty in Girls
Pediatrics, 06/10/09

Osteoprotegerin as an independent marker of subclinical atherosclerosis in osteoporotic postmenopausal women
Atherosclerosis, 06/04/09

See All of Reproductive Endocrinology